DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+10.83%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.99B
AUM Growth
+$2.99B
(-2.3%)
Cap. Flow
-$245M
Cap. Flow
% of AUM
-8.2%
Top 10 Holdings %
Top 10 Hldgs %
35.72%
Holding
154
New
30
Increased
26
Reduced
34
Closed
30
Top Buys
| 1 |
Viatris
VTRS
|
$58.4M |
| 2 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$56.5M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$38.2M |
| 4 |
DYAX
DYAX CORPORATION
DYAX
|
$35.8M |
| 5 |
Galapagos
GLPG
|
$33.1M |
Top Sells
| 1 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$446M |
| 2 |
AbbVie
ABBV
|
$89.8M |
| 3 |
Adverum Biotechnologies
ADVM
|
$85.8M |
| 4 |
BLUE
bluebird bio
BLUE
|
$51.3M |
| 5 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$27.7M |
Sector Composition
| 1 | Healthcare | 71.13% |
| 2 | Financials | 3.44% |
| 3 | Technology | 0.52% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GHDX
26
DELISTED
Genomic Health, Inc.
GHDX
| $32.9M | 1.1% |
+1,183,000
| New | +$32.9M |
|
|
ARNA
27
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $32.4M | 1.08% |
6,983,710
-2,245,669
| -24% | -$10.4M |
|
28
Xencor
XNCR
$594M
| $31M | 1.03% |
1,411,000
-484,535
| -26% | -$10.6M |
|
29
McKesson
MCK
$85.9B
| $30.6M | 1.02% |
136,000
+44,000
| +48% | +$9.89M |
|
30
Edwards Lifesciences
EW
$47.7B
| $30.2M | 1.01% |
+211,850
| New | +$30.2M |
|
|
ZLTQ
31
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $30M | 1% |
+1,016,453
| New | +$30M |
|
|
TVTY
32
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $29.5M | 0.98% |
+2,465,042
| New | +$29.5M |
|
|
GI
33
DELISTED
EndoChoice Holdings, Inc.
GI
| $29.4M | 0.98% |
+1,797,709
| New | +$29.4M |
|
|
INFI
34
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $27M | 0.9% |
2,465,129
-1,503,026
| -38% | -$16.5M |
|
35
Inogen
INGN
$213M
| $26.8M | 0.89% |
601,772
| – | – |
|
|
LOXO
36
DELISTED
Loxo Oncology, Inc
LOXO
| $26.1M | 0.87% |
1,450,151
-141,395
| -9% | -$2.55M |
|
37
Boston Scientific
BSX
$159B
| $24.9M | 0.83% |
+1,405,348
| New | +$24.9M |
|
38
Elevance Health
ELV
$72.4B
| $23.1M | 0.77% |
140,806
+41,064
| +41% | +$6.74M |
|
39
Protara Therapeutics
TARA
$125M
| $22.6M | 0.75% |
1,265,343
| – | – |
|
|
SAGE
40
DELISTED
Sage Therapeutics
SAGE
| $22.3M | 0.74% |
305,000
-290,443
| -49% | -$21.2M |
|
41
Insmed
INSM
$30.3B
| $21.8M | 0.73% |
891,546
-736,985
| -45% | -$18M |
|
|
NUVA
42
DELISTED
NuVasive, Inc.
NUVA
| $21.3M | 0.71% |
450,272
+112,078
| +33% | +$5.31M |
|
|
ELOS
43
DELISTED
Syneron Medical Ltd
ELOS
| $21M | 0.7% |
1,973,945
+1,348,352
| +216% | +$14.3M |
|
|
ALIM
44
DELISTED
Alimera Sciences, Inc.
ALIM
| $20.4M | 0.68% |
4,420,580
| – | – |
|
45
Zevra Therapeutics
ZVRA
$501M
| $19.9M | 0.66% |
+1,084,443
| New | +$19.9M |
|
|
NSTG
46
DELISTED
NanoString Technologies, Inc.
NSTG
| $19M | 0.63% |
1,232,696
-227,956
| -16% | -$3.52M |
|
|
RAD
47
DELISTED
Rite Aid Corporation
RAD
| $15.8M | 0.53% |
1,890,000
+1,837,236
| +3,482% | +$15.3M |
|
|
IMPR
48
DELISTED
IMPRIVATA, INC COM
IMPR
| $15.7M | 0.52% |
958,152
-67,500
| -7% | -$1.1M |
|
49
Orthofix Medical
OFIX
$583M
| $15.2M | 0.51% |
457,699
-172,523
| -27% | -$5.71M |
|
|
AKRX
50
DELISTED
Akorn, Inc.
AKRX
| $15M | 0.5% |
+344,667
| New | +$15M |
|